• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAP1肿瘤易感性综合征患者发生的黑色素瘤的独特皮肤镜和组织病理学特征。

Unique Dermoscopic and Histopathologic Features of Melanoma Arising in a Patient With BAP1 Tumor Predisposition Syndrome.

作者信息

Grisham Eric A, Tadros Joseph, Smith Emily

机构信息

Dermatology, University of Missouri, Columbia, USA.

Internal Medicine, Providence Sacred Heart, Spokane, USA.

出版信息

Cureus. 2021 Aug 27;13(8):e17485. doi: 10.7759/cureus.17485. eCollection 2021 Aug.

DOI:10.7759/cureus.17485
PMID:34646590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8478628/
Abstract

Breast cancer gene 1 ()-Associated Protein Tumor Predisposition Syndrome (BAP1-TPDS) is a relatively newly discovered syndrome that may develop a variety of malignancies, including atypical melanoma resembling Spitz nevi. Dermoscopic and molecular findings aid in diagnosing melanoma in BAP1-TPDS, and clinicians should have a high index of suspicion and a low threshold for screening and diagnostic testing for cutaneous malignancies in these patients. We describe an atypical, amelanotic melanoma in a 45-year-old male with a history of BAP1-TPDS and nodular melanoma. The patient presented with a rapidly evolving lesion on the right arm. Given the patient's prior history of melanoma and of heterozygous gene mutation, histopathological and molecular analysis was performed on the lesion, revealing a diffuse loss of expression and multiple chromosomal aberrancies. In these cases, histopathological and molecular analysis remain the keys to diagnosis, but astute dermoscopic evaluation may help clinicians avoid initial diagnostic confusion and delays in treatment. Melanoma should always be considered in patients with BAP1-TPDS, even in the absence of classic gross, dermoscopic, histopathological, and molecular characteristics of typical melanoma.

摘要

乳腺癌1基因()相关蛋白肿瘤易感性综合征(BAP1-TPDS)是一种相对较新发现的综合征,可能会引发多种恶性肿瘤,包括类似斯皮茨痣的非典型黑色素瘤。皮肤镜和分子检查结果有助于诊断BAP1-TPDS患者的黑色素瘤,临床医生对这些患者的皮肤恶性肿瘤筛查和诊断测试应保持高度怀疑指数并降低阈值。我们描述了一名45岁男性,有BAP1-TPDS病史和结节性黑色素瘤,其患有一种非典型无色素性黑色素瘤。患者右臂出现一个迅速发展的病灶。鉴于患者既往有黑色素瘤病史和杂合子基因突变,对该病灶进行了组织病理学和分子分析,结果显示表达弥漫性缺失和多个染色体异常。在这些病例中,组织病理学和分子分析仍然是诊断的关键,但敏锐的皮肤镜评估可能有助于临床医生避免最初的诊断混淆和治疗延误。即使没有典型黑色素瘤的经典大体、皮肤镜、组织病理学和分子特征,BAP1-TPDS患者也应始终考虑患有黑色素瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/941e22aa50c0/cureus-0013-00000017485-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/214b93eeb7ca/cureus-0013-00000017485-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/56a9ffb0b2f1/cureus-0013-00000017485-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/06f8ce3762e0/cureus-0013-00000017485-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/e4a3ecde0140/cureus-0013-00000017485-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/941e22aa50c0/cureus-0013-00000017485-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/214b93eeb7ca/cureus-0013-00000017485-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/56a9ffb0b2f1/cureus-0013-00000017485-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/06f8ce3762e0/cureus-0013-00000017485-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/e4a3ecde0140/cureus-0013-00000017485-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33f4/8478628/941e22aa50c0/cureus-0013-00000017485-i05.jpg

相似文献

1
Unique Dermoscopic and Histopathologic Features of Melanoma Arising in a Patient With BAP1 Tumor Predisposition Syndrome.BAP1肿瘤易感性综合征患者发生的黑色素瘤的独特皮肤镜和组织病理学特征。
Cureus. 2021 Aug 27;13(8):e17485. doi: 10.7759/cureus.17485. eCollection 2021 Aug.
2
Tumor Predisposition Syndrome肿瘤易感性综合征
3
Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.患者双侧葡萄膜黑色素瘤并发独立于 BAP1 肿瘤易感性综合征的基底细胞癌:识别 BAP1-TPDS 患者的诊断挑战。
Genes Chromosomes Cancer. 2019 Jun;58(6):357-364. doi: 10.1002/gcc.22724. Epub 2019 Jan 23.
4
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.荷兰的BAP1肿瘤易感综合征家庭:识别途径及遗传筛查指南建议
Cancers (Basel). 2019 Aug 4;11(8):1114. doi: 10.3390/cancers11081114.
5
Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.皮肤 BAP1 失活的黑色素瘤的临床和皮肤镜特征:国际皮肤镜学会多中心病例对照研究的结果。
J Am Acad Dermatol. 2019 Jun;80(6):1585-1593. doi: 10.1016/j.jaad.2018.09.014. Epub 2018 Sep 20.
6
BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.BAP1和BRAFV600E在良性和恶性黑素细胞增殖中的表达
Hum Pathol. 2015 Feb;46(2):239-45. doi: 10.1016/j.humpath.2014.10.015. Epub 2014 Nov 4.
7
BAP1 germline variants in Finnish patients with malignant mesothelioma.芬兰恶性间皮瘤患者的BAP1种系变异
Lung Cancer. 2022 Mar;165:102-107. doi: 10.1016/j.lungcan.2022.01.017. Epub 2022 Jan 24.
8
BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.BAP1综合征——易患恶性间皮瘤、皮肤和葡萄膜黑色素瘤、肾癌及其他癌症。
Klin Onkol. 2019 Summer;32(Supplementum2):118-122. doi: 10.14735/amko2019S118.
9
Diagnostics of -Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience.通过多检测方法诊断肿瘤易感性综合征:十年经验
Diagnostics (Basel). 2022 Jul 13;12(7):1710. doi: 10.3390/diagnostics12071710.
10
An adolescent with uveal melanoma and tumor predisposition syndrome.一名患有葡萄膜黑色素瘤和肿瘤易感性综合征的青少年。
JAAD Case Rep. 2020 Apr 25;6(6):563-566. doi: 10.1016/j.jdcr.2020.04.018. eCollection 2020 Jun.

本文引用的文献

1
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.荷兰的BAP1肿瘤易感综合征家庭:识别途径及遗传筛查指南建议
Cancers (Basel). 2019 Aug 4;11(8):1114. doi: 10.3390/cancers11081114.
2
BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.BRCA1相关蛋白(BAP1)失活的黑素细胞肿瘤
J Cutan Pathol. 2019 Dec;46(12):965-972. doi: 10.1111/cup.13530. Epub 2019 Jul 11.
3
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
皮肤黑色素瘤临床实践指南(第 2 版).2019,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Apr 1;17(4):367-402. doi: 10.6004/jnccn.2019.0018.
4
Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.无BAP1相关癌症易感性综合征家族史患者中BAP1表达缺失的黑色素瘤:病例系列
Am J Dermatopathol. 2019 Mar;41(3):167-179. doi: 10.1097/DAD.0000000000001217.
5
Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.皮肤 BAP1 失活的黑色素瘤的临床和皮肤镜特征:国际皮肤镜学会多中心病例对照研究的结果。
J Am Acad Dermatol. 2019 Jun;80(6):1585-1593. doi: 10.1016/j.jaad.2018.09.014. Epub 2018 Sep 20.
6
Germline mutations in BAP1 predispose to melanocytic tumors.胚系 BAP1 基因突变可导致黑色素细胞肿瘤。
Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910.
7
Frequent mutation of BAP1 in metastasizing uveal melanomas.转移性葡萄膜黑色素瘤中 BAP1 的频繁突变。
Science. 2010 Dec 3;330(6009):1410-3. doi: 10.1126/science.1194472. Epub 2010 Nov 4.
8
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.BRCA1相关蛋白-1是一种肿瘤抑制因子,它需要去泛素化活性和核定位。
Cancer Res. 2008 Sep 1;68(17):6953-62. doi: 10.1158/0008-5472.CAN-08-0365.